{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:44:43Z","timestamp":1785415483646,"version":"3.56.0"},"posted":{"date-parts":[[2025,7,15]]},"group-title":"Cancer Biology","reference-count":60,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"award":["R01CA196973"],"award-info":[{"award-number":["R01CA196973"]}],"id":[{"id":"https:\/\/ror.org\/040gcmg81","id-type":"ROR","asserted-by":"publisher"}]},{"award":["P30CA013330"],"award-info":[{"award-number":["P30CA013330"]}],"id":[{"id":"https:\/\/ror.org\/040gcmg81","id-type":"ROR","asserted-by":"publisher"}]},{"id":[{"id":"https:\/\/ror.org\/00kbbk236","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["TL1TR002557"],"award-info":[{"award-number":["TL1TR002557"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["2K12GH102779-07A1"],"award-info":[{"award-number":["2K12GH102779-07A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["S10OD030286"],"award-info":[{"award-number":["S10OD030286"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["1S10OD026833-01"],"award-info":[{"award-number":["1S10OD026833-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"crossref","award":["F32HL146119"],"award-info":[{"award-number":["F32HL146119"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Alexandrine and Alexander L. Sinsheimer Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,4,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Acquired non-genetic resistance mechanisms to existing therapies contribute to poor outcomes for acute myeloid leukemia (AML) patients, and inability to target leukemic stem cells (LSCs) can lead to relapse. To overcome these challenges, we tested whether LSCs have dependencies on PI3 kinase (PI3K). We found that LSCs are susceptible to isoform-selective targeting of PI3K and are particularly dependent on the P110 alpha isoform of PI3K. We discovered that PI3K inactivation leads to dynamic changes in EZH2\/PRC2 function in leukemic cells, and we uncovered downregulation of EZH2 protein levels as a resistance mechanism in response to PI3K inhibition. We found that PI3K inhibition in AML cells can lead to compensatory upregulation of EZH1, and that EZH1 knockdown can sensitize AML cells to PI3K inhibition. We leveraged this resistance mechanism by combining a PI3K inhibitor with an EZH1\/2 dual inhibitor, which successfully overcomes the acquired resistance and leads to sustained targeting of AML cells ex vivo and in murine AML and PDX models in vivo. This study identifies a promising novel therapeutic regimen for targeting LSCs in AML.<\/jats:p>","DOI":"10.1101\/2025.07.11.663968","type":"posted-content","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T08:35:20Z","timestamp":1752568520000},"source":"Crossref","is-referenced-by-count":0,"title":["Exploiting an Epigenetic Resistance Mechanism to PI3 Kinase Inhibition in Leukemic Stem Cells"],"prefix":"10.64898","author":[{"given":"Shira G.","family":"Glushakow-Smith","sequence":"first","affiliation":[{"name":"Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY"},{"name":"Department of Medicine, Montefiore Hospital, Bronx, NY"},{"name":"Department of Oncology, Montefiore Hospital, Bronx, NY"},{"name":"Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imit","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY"},{"name":"Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Sidoli","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayda","family":"Hemmati","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY"},{"name":"Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Angeles","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY"},{"name":"Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taneisha","family":"Sinclair","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY"},{"name":"Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samarpana","family":"Chakraborty","sequence":"additional","affiliation":[{"name":"Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine, Albert Einstein College of Medicine, Bronx, NY"},{"name":"Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaliyah","family":"Battle","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Ames","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY"},{"name":"Department of Medicine, Montefiore Hospital, Bronx, NY"},{"name":"Department of Oncology, Montefiore Hospital, Bronx, NY"},{"name":"Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swathi-Rao","family":"Narayanagari","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY"},{"name":"Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rotila","family":"Hyka","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY"},{"name":"Department of Medicine, Montefiore Hospital, Bronx, NY"},{"name":"Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Soto","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY"},{"name":"Department of Medicine, Montefiore Hospital, Bronx, NY"},{"name":"Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Tracy","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayaram","family":"Vankudoth","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2453-849X","authenticated-orcid":false,"given":"Seiya","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linde","family":"Miles","sequence":"additional","affiliation":[{"name":"Division of Experimental Hematology and Cancer Biology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati OH"},{"name":"Department of Pediatrics, University of Cincinnati, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Steidl","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY"},{"name":"Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Shastri","sequence":"additional","affiliation":[{"name":"Department of Medicine, Montefiore Hospital, Bronx, NY"},{"name":"Department of Oncology, Montefiore Hospital, Bronx, NY"},{"name":"Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine, Albert Einstein College of Medicine, Bronx, NY"},{"name":"Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Medicine, Montefiore Hospital, Bronx, NY"},{"name":"Department of Oncology, Montefiore Hospital, Bronx, NY"},{"name":"Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine, Albert Einstein College of Medicine, Bronx, NY"},{"name":"Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1367-1167","authenticated-orcid":false,"given":"Kira","family":"Gritsman","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY"},{"name":"Department of Medicine, Montefiore Hospital, Bronx, NY"},{"name":"Department of Oncology, Montefiore Hospital, Bronx, NY"},{"name":"Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine, Albert Einstein College of Medicine, Bronx, NY"},{"name":"Center for Tumor Dormancy, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026041306550458000_2025.07.11.663968v2.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.02.018"},{"key":"2026041306550458000_2025.07.11.663968v2.2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.280800"},{"key":"2026041306550458000_2025.07.11.663968v2.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04206-7"},{"key":"2026041306550458000_2025.07.11.663968v2.4","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2651"},{"key":"2026041306550458000_2025.07.11.663968v2.5","doi-asserted-by":"crossref","unstructured":"Nepstad I , Hatfield KJ , Gronningsaeter IS , Reikvam H . The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells. Int J Mol Sci. 2020;21(8).","DOI":"10.3390\/ijms21082907"},{"key":"2026041306550458000_2025.07.11.663968v2.6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403653"},{"key":"2026041306550458000_2025.07.11.663968v2.7","first-page":"1","article-title":"Signaling Pathways in Leukemic Stem Cells","volume":"1143","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"2026041306550458000_2025.07.11.663968v2.8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402874"},{"key":"2026041306550458000_2025.07.11.663968v2.9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-06-229443"},{"key":"2026041306550458000_2025.07.11.663968v2.10","doi-asserted-by":"publisher","DOI":"10.1038\/nature04703"},{"key":"2026041306550458000_2025.07.11.663968v2.11","doi-asserted-by":"publisher","DOI":"10.1038\/nature04747"},{"key":"2026041306550458000_2025.07.11.663968v2.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0129-z"},{"key":"2026041306550458000_2025.07.11.663968v2.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-015-1352-5"},{"issue":"7","key":"2026041306550458000_2025.07.11.663968v2.14","first-page":"206","article-title":"induces apoptosis of AML cells and enhances the cytotoxicity of cytarabine","volume":"32","year":"2206","journal-title":"Med Oncol"},{"key":"2026041306550458000_2025.07.11.663968v2.15","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.144"},{"key":"2026041306550458000_2025.07.11.663968v2.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-013-1076-3"},{"issue":"4","key":"2026041306550458000_2025.07.11.663968v2.17","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/leu.2014.305","article-title":"Dual PI3K\/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia","volume":"29","year":"2015","journal-title":"Leukemia"},{"key":"2026041306550458000_2025.07.11.663968v2.18","doi-asserted-by":"crossref","unstructured":"Fransecky L , Mochmann LH , Baldus CD . Outlook on PI3K\/AKT\/mTOR inhibition in acute leukemia. Mol Cell Ther. 2015;3:2.","DOI":"10.1186\/s40591-015-0040-8"},{"key":"2026041306550458000_2025.07.11.663968v2.19","doi-asserted-by":"crossref","unstructured":"Hemmati S , Sinclair T , Tong M , Bartholdy B , Okabe RO , Ames K , et al. PI3 kinase alpha and delta promote hematopoietic stem cell activation. JCI Insight. 2019;5(13).","DOI":"10.1172\/jci.insight.125832"},{"key":"2026041306550458000_2025.07.11.663968v2.20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9501"},{"key":"2026041306550458000_2025.07.11.663968v2.21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI69927"},{"issue":"8015","key":"2026041306550458000_2025.07.11.663968v2.22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41586-024-07410-3","article-title":"Targetable leukaemia dependency on noncanonical PI3Kgamma signalling","volume":"630","year":"2024","journal-title":"Nature"},{"issue":"19","key":"2026041306550458000_2025.07.11.663968v2.23","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1182\/blood.2023022202","article-title":"PI3Kgamma maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathway","volume":"143","year":"2024","journal-title":"Blood"},{"issue":"7","key":"2026041306550458000_2025.07.11.663968v2.24","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s43018-024-00782-5","article-title":"Targeting a lineage-specific PI3K -Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader molecule","volume":"5","year":"2024","journal-title":"Nat Cancer"},{"key":"2026041306550458000_2025.07.11.663968v2.25","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00209-1"},{"key":"2026041306550458000_2025.07.11.663968v2.26","doi-asserted-by":"crossref","unstructured":"Rinke J , Chase A , Cross NCP , Hochhaus A , Ernst T . EZH2 in Myeloid Malignancies. Cells. 2020;9(7).","DOI":"10.3390\/cells9071639"},{"key":"2026041306550458000_2025.07.11.663968v2.27","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20181276"},{"key":"2026041306550458000_2025.07.11.663968v2.28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-634428"},{"key":"2026041306550458000_2025.07.11.663968v2.29","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0152"},{"issue":"8","key":"2026041306550458000_2025.07.11.663968v2.30","doi-asserted-by":"crossref","first-page":"eade8222","DOI":"10.1126\/sciadv.ade8222","article-title":"PI3-kinase deletion promotes myelodysplasia by dysregulating autophagy in hematopoietic stem cells","volume":"9","year":"2023","journal-title":"Sci Adv"},{"key":"2026041306550458000_2025.07.11.663968v2.31","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.525"},{"key":"2026041306550458000_2025.07.11.663968v2.32","doi-asserted-by":"crossref","unstructured":"Sidoli S , Bhanu NV , Karch KR , Wang X , Garcia BA . Complete Workflow for Analysis of Histone Post-translational Modifications Using Bottom-up Mass Spectrometry: From Histone Extraction to Data Analysis. J Vis Exp. 2016(111).","DOI":"10.3791\/54112"},{"key":"2026041306550458000_2025.07.11.663968v2.33","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.8b00133"},{"key":"2026041306550458000_2025.07.11.663968v2.34","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2253"},{"key":"2026041306550458000_2025.07.11.663968v2.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.05.007"},{"key":"2026041306550458000_2025.07.11.663968v2.36","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20070003"},{"key":"2026041306550458000_2025.07.11.663968v2.37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-271171"},{"key":"2026041306550458000_2025.07.11.663968v2.38","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-12-0993-T"},{"key":"2026041306550458000_2025.07.11.663968v2.39","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-11-0474"},{"key":"2026041306550458000_2025.07.11.663968v2.40","doi-asserted-by":"publisher","DOI":"10.1038\/nature07091"},{"key":"2026041306550458000_2025.07.11.663968v2.41","doi-asserted-by":"publisher","DOI":"10.1038\/nature04980"},{"key":"2026041306550458000_2025.07.11.663968v2.42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"2026041306550458000_2025.07.11.663968v2.43","doi-asserted-by":"publisher","DOI":"10.1038\/S41592-023-02014-7"},{"key":"2026041306550458000_2025.07.11.663968v2.44","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.300"},{"key":"2026041306550458000_2025.07.11.663968v2.45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-06-581082"},{"key":"2026041306550458000_2025.07.11.663968v2.46","doi-asserted-by":"crossref","unstructured":"Chakraborty S , Morganti C , Zaldana K , Rivera Pena B , Zhang H , Verma D , et al. A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia. Leukemia. 2026.","DOI":"10.1038\/s41375-026-02883-9"},{"key":"2026041306550458000_2025.07.11.663968v2.47","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-760595"},{"key":"2026041306550458000_2025.07.11.663968v2.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2009.06.008"},{"issue":"1","key":"2026041306550458000_2025.07.11.663968v2.49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ajh.24568","article-title":"Buparlisib, a PI3K inhibitor, demonstrates acceptable tolerability and preliminary activity in a phase I trial of patients with advanced leukemias","volume":"92","year":"2017","journal-title":"Am J Hematol"},{"key":"2026041306550458000_2025.07.11.663968v2.50","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16723"},{"key":"2026041306550458000_2025.07.11.663968v2.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.07.032"},{"key":"2026041306550458000_2025.07.11.663968v2.52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202258109"},{"key":"2026041306550458000_2025.07.11.663968v2.53","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4247"},{"key":"2026041306550458000_2025.07.11.663968v2.54","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-02131-4"},{"key":"2026041306550458000_2025.07.11.663968v2.55","doi-asserted-by":"publisher","DOI":"10.1126\/science.1118947"},{"key":"2026041306550458000_2025.07.11.663968v2.56","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-1297"},{"issue":"3","key":"2026041306550458000_2025.07.11.663968v2.57","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.clml.2018.11.021","article-title":"Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas","volume":"19","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2026041306550458000_2025.07.11.663968v2.58","doi-asserted-by":"crossref","unstructured":"Sirico M , D\u2019Angelo A , Gianni C , Casadei C , Merloni F , De Giorgi U . Current State and Future Challenges for PI3K Inhibitors in Cancer Therapy. Cancers (Basel). 2023;15(3).","DOI":"10.3390\/cancers15030703"},{"key":"2026041306550458000_2025.07.11.663968v2.59","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-023-03440-4"},{"key":"2026041306550458000_2025.07.11.663968v2.60","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016862"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.07.11.663968","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:55:22Z","timestamp":1776088522000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.07.11.663968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":60,"URL":"https:\/\/doi.org\/10.1101\/2025.07.11.663968","relation":{},"subject":[],"published":{"date-parts":[[2025,7,15]]},"subtype":"preprint"}}